(Q36121961)

12 August 2017

1 reference

title

Imaging of pheochromocytoma and paraganglioma (English)

1 reference

12 August 2017

1 reference

Brink I

1

1 reference

12 August 2017

Hoegerle S

series ordinal

2

1 reference

12 August 2017

Klisch J

series ordinal

3

1 reference

12 August 2017

Bley TA

series ordinal

4

1 reference

12 August 2017

1 January 2005

1 reference

12 August 2017

1 reference

12 August 2017

4

1 reference

12 August 2017

1

1 reference

12 August 2017

61-68

1 reference

https://scigraph.springernature.com/pub.10.1007/s10689-004-2155-y

12 August 2017

0 references

cites work

Characterization of adrenal masses (< 5 cm) by use of chemical shift MR imaging: observer performance versus quantitative measures.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10689-004-2155-Y

Integrated imaging of adrenal disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10689-004-2155-Y

Dynamic contrast enhancement of paragangliomas of the head and neck: evaluation with time-resolved 2D MR projection angiography.

21 January 2018

1 reference

12 December 2020

Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma

1 reference

12 December 2020

MR imaging of adrenal masses: value of chemical-shift imaging for distinguishing adenomas from other tumors

1 reference

12 December 2020

Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients

1 reference

12 December 2020

Familial Multiple Glomus Tumors and Pheochromocytomas

1 reference

12 December 2020

[Positron emission tomography (PET) with fludeoxyglucose F 18 in the study of adrenal masses: comparison of benign and malignant lesions]

1 reference

12 December 2020

Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease

1 reference

12 December 2020

Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours.

1 reference

12 December 2020

Neuroendocrine neoplasms and their cells of origin

1 reference

12 December 2020

18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels

1 reference

12 December 2020

MR differentiation of phaeochromocytoma from other adrenal lesions based on qualitative analysis of T2 relaxation times

1 reference

12 December 2020

Malignant pheochromocytoma of the anterior mediastinum: PET findings with [18F]FDG and 82Rb

1 reference

12 December 2020

Pheochromocytoma and paraganglioma: comparison of MR imaging with CT and I-131 MIBG scintigraphy

1 reference

12 December 2020

A radiopharmaceuticals schedule for imaging in paediatrics. Paediatric Task Group European Association Nuclear Medicine

1 reference

12 December 2020

18F-FDG PET in characterizing adrenal lesions detected on CT or MRI.

1 reference

12 December 2020

Radio-iodobenzylguanidine for the scintigraphic location and therapy of adrenergic tumors

1 reference

12 December 2020

A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG)

1 reference

12 December 2020

Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences

1 reference

12 December 2020

Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors

1 reference

12 December 2020

An expanded concept of tumors of glomic tissue

1 reference

12 December 2020

Adrenal gland: MR imaging

1 reference

12 December 2020

Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.

1 reference

12 December 2020

Benign adrenocortical masses: diagnosis with chemical shift MR imaging

1 reference

12 December 2020

Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography

1 reference

12 December 2020

Octreotide scintigraphy and catecholamine response to an octreotide challenge in malignant phaeochromocytoma.

1 reference

12 December 2020

Adrenal gland: MR imaging

1 reference

12 December 2020

Diagnostic imaging in patients with paragangliomas. Computed tomography, magnetic resonance and MIBG scintigraphy comparison

1 reference

12 December 2020

Pheochromocytoma: effect of nonionic contrast medium in CT on circulating catecholamine levels

1 reference

12 December 2020

Familial carotid body tumors: case report and epidemiologic review

1 reference

12 December 2020

Pheochromocytoma: a clinical and experimental overview

1 reference

12 December 2020

Localization of pheochromocytoma: MIBG [correction of MIGB], CT, and MRI correlation

1 reference

12 December 2020

18F-DOPA positron emission tomography for the detection of glomus tumours

1 reference

12 December 2020

Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells

1 reference

12 December 2020

Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma

1 reference

12 December 2020

Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma

1 reference

12 December 2020

Histopathology, cytology and cytochemistry of pheochromocytomas and paragangliomas including chemodectomas

1 reference

12 December 2020

Pheochromocytomas: detection with 18F DOPA whole body PET--initial results..

1 reference

12 December 2020

Germ-line mutations in nonsyndromic pheochromocytoma

1 reference

12 December 2020

Octreotide scintigraphy for the detection of paragangliomas

1 reference

12 December 2020

6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma

1 reference

12 December 2020

Endocrine imaging: parathyroid, adrenal cortex and medulla, and other endocrine tumors. Part II.

1 reference

12 December 2020

Radiolabeled adrenergi neuron-blocking agents: adrenomedullary imaging with [131I]iodobenzylguanidine

1 reference

12 December 2020

Incidentally discovered adrenal masses

1 reference

12 December 2020

Pheochromocytomas: imaging with 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET

1 reference

12 December 2020

The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy

1 reference

12 December 2020

Pheochromocytoma: value of computed tomography

1 reference

12 December 2020

In vivo demonstration of enzyme activity in endocrine pancreatic tumors: decarboxylation of carbon-11-DOPA to carbon-11-dopamine

1 reference

12 December 2020

10.1007/S10689-004-2155-Y

Identifiers

DOI

1 reference

12 August 2017

1 reference